Emerging Treatments in Aging-Related Cerebrovascular Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 27
Special Issue Editor
2. Experimental Research Center for Normal and Pathological Aging Director, University of Medicine and Pharmacy of Craiova, Craiova, Romania
Interests: ageing; cerebrovascular diseases; rehabilitation; cell therapies; genomics; proteomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Aging is a primary risk factor for cerebrovascular diseases (CVDs), including stroke and vascular dementia, which remain leading causes of disability and mortality worldwide. Recent advances in biomedical research have identified novel therapeutic tools targeting the underlying mechanisms of aging and vascular degeneration.
Author contributions include senolytic drugs that selectively eliminate senescent cells, gene editing technologies such as CRISPR/Cas9 that correct age-related genetic mutations, and RNA-based therapies for modulating inflammatory and metabolic pathways. Stem cell-based interventions, particularly those using induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs), show promise in promoting neurovascular repair and functional recovery post-stroke. Additionally, bioengineered nanocarriers and blood–brain barrier-permeable delivery systems have improved the precision and efficacy of drug administration to affected brain regions. Chronotherapy and circadian modulation are also emerging as tools to optimize treatment timing, aligning interventions with biological rhythms for enhanced outcomes. Together, these therapeutic innovations represent a paradigm shift toward personalized, regenerative, and preventive approaches in treating aging-related cerebrovascular diseases. Continued translational research and clinical trials are essential for fully realizing their potential and ensuring their safe, effective integration into clinical practice.
Prof. Dr. Aurel Popa-Wagner
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- aging
- cerebrovascular diseases
- therapeutic tools
- senolytic drugs
- gene editing technologies
- RNA-based therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
